Akt/mTOR signaling activation ultimately causes autophagy repression in cancer cells and increases NSCLC development, rendering resistance of NSCLC cells to various cancer therapies and leading to a poor prognosis (16, 17). Here, AKT1 is linked to non-small cell lung carcinoma.